WO2023223268 - PROTEINS FOR REGULATION OF SYMBIOTIC NODULE ORGAN IDENTITY
National phase entry:
Publication Number
WO/2023/223268
Publication Date
23.11.2023
International Application No.
PCT/IB2023/055144
International Filing Date
18.05.2023
Title **
[English]
PROTEINS FOR REGULATION OF SYMBIOTIC NODULE ORGAN IDENTITY
[French]
PROTÉINES POUR LA RÉGULATION D'IDENTITÉ D'ORGANE DE NODULE SYMBIOTIQUE
Applicants **
CAMBRIDGE ENTERPRISE LIMITED
Inventors
OLDROYD, Giles Edward Dixon
SCHIESSL, Katharina
LEE, Tak
JHU, Min-Yao
Priority Data
63/343,950
19.05.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3285 | |
| EPO | Filing, Examination, Granting | 23862 | |
| Japan | Filing, Examination, Granting | 2985 | |
| South Korea | Filing, Examination, Granting | 3768 | |
| USA | Filing, Examination, Granting | 16190 |
Total:
50,090
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention provides novel DNA molecules and constructs, including their nucleotide sequences, useful for expressing proteins in plants to promote symbiotic infection. The invention also provides plants and plant cells transgenic plants, plant cells, plant parts, seeds, and commodity products comprising the DNA molecules operably linked to heterologous transcribable polynucleotides, along with methods of their use.[French]
La présente invention concerne de nouvelles molécules d'ADN et de nouvelles constructions, y compris leurs séquences nucléotidiques, utiles pour exprimer des protéines dans des plantes afin de favoriser une infection symbiotique. L'invention concerne également des plantes et des cellules végétales transgéniques, des cellules végétales, des parties de plantes, des graines et des produits de base comprenant les molécules d'ADN liées de manière fonctionnelle à des polynucléotides hétérologues pouvant être transcrits, ainsi que leurs procédés d'utilisation.